Antimicrobial Use

We need to understand how antimicrobials are used and by whom and how these factors contribute to misuse of antimicrobials

You are here

The first pillar of our strategy aims to increase the understanding of how antimicrobials are used in LMIC’s settings, particularly those classified by WHO as Critical Important Antibiotics (CIA), the distribution networks of antimicrobials, the role of formal and informal markets in perpetuating cycles of inequity and lack of access to secure food, and how incentives for reduction of antimicrobial use can be introduced to achieve an appropriate level of use. To increase the understanding of these topics, including the role women play in decision making on use of antimicrobials, we integrate social science in our research using knowledge, attitudes and practices (KAP’s) methodologies, interviews, surveys, and work closely with communities and other relevant stakeholders. 

 

Our main activities are:

  • Develop metrics for antimicrobial use in livestock systems and collect and collate data on use of antimicrobials in livestock, aquaculture, and crops (antibiotic classes, dosage);
  • Understand farmer behaviour and gender relations in antimicrobial use to provide entry points for interventions and incentives promoting behaviour change;
  • Understand governance of antimicrobials used in humans, livestock, fish, and crops; 
  • Assess the quality of antimicrobials used in humans, livestock, fish, and crops;
  • Use system approaches to identify possible hotspots for AM use and possible AMR exposure for people;
  • Map formal and informal antimicrobial value chains and assess markets and access of producers to these markets.

 

The case studies featured below illustrate ongoing and past research and provide insights into how AMR research is done within the CGIAR AMR hub.